BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dardiotis E, Tsouris Z, Mentis AA, Siokas V, Michalopoulou A, Sokratous M, Dastamani M, Bogdanos DP, Deretzi G, Kountouras J. H. pylori and Parkinson's disease: Meta-analyses including clinical severity. Clin Neurol Neurosurg. 2018;175:16-24. [PMID: 30308319 DOI: 10.1016/j.clineuro.2018.09.039] [Cited by in Crossref: 41] [Cited by in F6Publishing: 35] [Article Influence: 10.3] [Reference Citation Analysis]
Number Citing Articles
1 Dardiotis E, Rikos D, Siokas V, Aloizou AM, Tsouris Z, Sakalakis E, Brotis AG, Bogdanos DP, Hadjigeorgiou GM. Assessment of TREM2 rs75932628 variant's association with Parkinson's disease in a Greek population and Meta-analysis of current data. Int J Neurosci 2021;131:544-8. [PMID: 32250197 DOI: 10.1080/00207454.2020.1750388] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
2 Santos MLC, de Brito BB, da Silva FAF, Sampaio MM, Marques HS, Oliveira e Silva N, de Magalhães Queiroz DM, de Melo FF. Helicobacter pylori infection: Beyond gastric manifestations. World J Gastroenterol 2020; 26(28): 4076-4093 [PMID: 32821071 DOI: 10.3748/wjg.v26.i28.4076] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 12] [Article Influence: 8.5] [Reference Citation Analysis]
3 Nousia A, Martzoukou M, Tsouris Z, Siokas V, Aloizou A, Liampas I, Nasios G, Dardiotis E. The Beneficial Effects of Computer-Based Cognitive Training in Parkinson’s Disease: A Systematic Review. Archives of Clinical Neuropsychology 2020;35:434-47. [DOI: 10.1093/arclin/acz080] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
4 Pfeiffer RF, Isaacson SH, Pahwa R. Clinical implications of gastric complications on levodopa treatment in Parkinson's disease. Parkinsonism Relat Disord 2020;76:63-71. [PMID: 32461054 DOI: 10.1016/j.parkreldis.2020.05.001] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
5 Tucker RM, Augustin AD, Hayee BH, Bjarnason I, Taylor D, Weller C, Charlett A, Dobbs SM, Dobbs RJ. Role of Helicobacters in Neuropsychiatric Disease: A Systematic Review in Idiopathic Parkinsonism. J Clin Med 2020;9:E2159. [PMID: 32650535 DOI: 10.3390/jcm9072159] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
6 Kang X, Ploner A, Roelstraete B, Khalili H, Williams DM, Pedersen NL, Ludvigsson JF, Wirdefeldt K. Association Between Microscopic Colitis and Parkinson's Disease in a Swedish Population. Mov Disord 2021;36:1919-26. [PMID: 33764622 DOI: 10.1002/mds.28594] [Reference Citation Analysis]
7 Murciano-Brea J, Garcia-Montes M, Geuna S, Herrera-Rincon C. Gut Microbiota and Neuroplasticity. Cells 2021;10:2084. [PMID: 34440854 DOI: 10.3390/cells10082084] [Reference Citation Analysis]
8 Dardiotis E, Sokratous M, Tsouris Z, Siokas V, Mentis AA, Aloizou A, Michalopoulou A, Bogdanos DP, Xiromerisiou G, Deretzi G, Kountouras J, Hadjigeorgiou GM. Association between Helicobacter py lori infection and Guillain‐Barré Syndrome: A meta‐analysis. Eur J Clin Invest 2020;50. [DOI: 10.1111/eci.13218] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Siokas V, Aloizou AM, Liampas I, Bakirtzis C, Tsouris Z, Sgantzos M, Liakos P, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Myelin-associated oligodendrocyte basic protein rs616147 polymorphism as a risk factor for Parkinson's disease. Acta Neurol Scand 2022;145:223-8. [PMID: 34694630 DOI: 10.1111/ane.13538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Ivan IF, Irincu VL, Diaconu Ș, Falup-Pecurariu O, Ciopleiaș B, Falup-Pecurariu C. Gastro-intestinal dysfunctions in Parkinson's disease (Review). Exp Ther Med 2021;22:1083. [PMID: 34447476 DOI: 10.3892/etm.2021.10517] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Li Y, Chen Y, Jiang L, Zhang J, Tong X, Chen D, Le W. Intestinal Inflammation and Parkinson's Disease. Aging Dis 2021;12:2052-68. [PMID: 34881085 DOI: 10.14336/AD.2021.0418] [Reference Citation Analysis]
12 Sian-hülsmann J. Wilful pathogens provoke a gut feeling in Parkinson’s disease. J Neural Transm. [DOI: 10.1007/s00702-021-02448-3] [Reference Citation Analysis]
13 Rajestary R, Landi L, Romanazzi G. Chitosan and postharvest decay of fresh fruit: Meta‐analysis of disease control and antimicrobial and eliciting activities. Comprehensive Reviews in Food Science and Food Safety 2021;20:563-82. [DOI: 10.1111/1541-4337.12672] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
14 Zendehdel A, Roham M. Role of Helicobacter pylori infection in the manifestation of old age-related diseases. Mol Genet Genomic Med 2020;8:e1157. [PMID: 32067423 DOI: 10.1002/mgg3.1157] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
15 Ullah H, Di Minno A, Santarcangelo C, Khan H, Xiao J, Arciola CR, Daglia M. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials. Molecules 2021;26:2272. [PMID: 33919894 DOI: 10.3390/molecules26082272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Hauser RA, LeWitt PA, Comella CL. On demand therapy for Parkinson's disease patients: Opportunities and choices. Postgrad Med 2021;133:721-7. [PMID: 34082655 DOI: 10.1080/00325481.2021.1936087] [Reference Citation Analysis]
17 Castillo-Álvarez F, Marzo-Sola ME. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed) 2019:S0213-4853(19)30082-9. [PMID: 31340904 DOI: 10.1016/j.nrl.2019.03.017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
18 Tao ZH, Han JX, Fang JY. Helicobacter pylori infection and eradication: Exploring their impacts on the gastrointestinal microbiota. Helicobacter 2020;25:e12754. [PMID: 32876377 DOI: 10.1111/hel.12754] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Siokas V, Aslanidou P, Aloizou A, Peristeri E, Stamati P, Liampas I, Arseniou S, Drakoulis N, Aschner M, Tsatsakis A, Mitsias PD, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. Does the CD33 rs3865444 Polymorphism Confer Susceptibility to Alzheimer’s Disease? J Mol Neurosci 2020;70:851-60. [DOI: 10.1007/s12031-020-01507-w] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
20 Franceschi F, Covino M, Roubaud Baudron C. Review: Helicobacter pylori and extragastric diseases. Helicobacter. 2019;24 Suppl 1:e12636. [PMID: 31486239 DOI: 10.1111/hel.12636] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
21 Chen H, Wang K, Scheperjans F, Killinger B. Environmental triggers of Parkinson's disease - Implications of the Braak and dual-hit hypotheses. Neurobiol Dis 2021;163:105601. [PMID: 34954321 DOI: 10.1016/j.nbd.2021.105601] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chao YX, Gulam MY, Chia NSJ, Feng L, Rotzschke O, Tan EK. Gut-Brain Axis: Potential Factors Involved in the Pathogenesis of Parkinson's Disease. Front Neurol 2020;11:849. [PMID: 32982910 DOI: 10.3389/fneur.2020.00849] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Yoon BW, Lim SH, Shin JH, Lee JW, Lee Y, Seo JH. Analysis of oral microbiome in glaucoma patients using machine learning prediction models. J Oral Microbiol 2021;13:1962125. [PMID: 34394853 DOI: 10.1080/20002297.2021.1962125] [Reference Citation Analysis]
24 Siokas V, Aloizou AM, Tsouris Z, Liampas I, Liakos P, Calina D, Docea AO, Tsatsakis A, Bogdanos DP, Hadjigeorgiou GM, Dardiotis E. ADORA2A rs5760423 and CYP1A2 rs762551 Polymorphisms as Risk Factors for Parkinson's Disease. J Clin Med 2021;10:381. [PMID: 33498513 DOI: 10.3390/jcm10030381] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
25 Chaiwiang N, Poyomtip T. Microbial dysbiosis and microbiota-gut-retina axis: The lesson from brain neurodegenerative diseases to primary open-angle glaucoma pathogenesis of autoimmunity. Acta Microbiol Immunol Hung 2019;66:541-58. [PMID: 31786943 DOI: 10.1556/030.66.2019.038] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
26 Castillo-Álvarez F, Marzo-Sola ME. Role of the gut microbiota in the development of various neurological diseases. Neurologia (Engl Ed) 2022;37:492-8. [PMID: 35779869 DOI: 10.1016/j.nrleng.2019.03.026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
27 Tansey MG, Romero-Ramos M. Immune system responses in Parkinson's disease: Early and dynamic. Eur J Neurosci 2019;49:364-83. [PMID: 30474172 DOI: 10.1111/ejn.14290] [Cited by in Crossref: 30] [Cited by in F6Publishing: 32] [Article Influence: 7.5] [Reference Citation Analysis]
28 Cannon T, Gruenheid S. Microbes and Parkinson’s disease: from associations to mechanisms. Trends in Microbiology 2022. [DOI: 10.1016/j.tim.2022.01.004] [Reference Citation Analysis]
29 Gravina AG, Priadko K, Ciamarra P, Granata L, Facchiano A, Miranda A, Dallio M, Federico A, Romano M. Extra-Gastric Manifestations of Helicobacter pylori Infection. J Clin Med 2020;9:E3887. [PMID: 33265933 DOI: 10.3390/jcm9123887] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
30 Fan HX, Sheng S, Zhang F. New hope for Parkinson's disease treatment: Targeting gut microbiota. CNS Neurosci Ther 2022. [PMID: 35822696 DOI: 10.1111/cns.13916] [Reference Citation Analysis]
31 Fried S, Wemelle E, Cani PD, Knauf C. Interactions between the microbiota and enteric nervous system during gut-brain disorders. Neuropharmacology 2021;197:108721. [PMID: 34274348 DOI: 10.1016/j.neuropharm.2021.108721] [Reference Citation Analysis]
32 Farmen K, Tofiño-Vian M, Iovino F. Neuronal Damage and Neuroinflammation, a Bridge Between Bacterial Meningitis and Neurodegenerative Diseases. Front Cell Neurosci 2021;15:680858. [PMID: 34149363 DOI: 10.3389/fncel.2021.680858] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
33 Kim TJ, Lee H. Benefits of Helicobacter pylori Eradication on Extragastric Diseases. Korean J Helicobacter Up Gastrointest Res 2021;21:275-86. [DOI: 10.7704/kjhugr.2021.0041] [Reference Citation Analysis]
34 Chiang HL, Lin CH. Altered Gut Microbiome and Intestinal Pathology in Parkinson's Disease. J Mov Disord 2019;12:67-83. [PMID: 31158941 DOI: 10.14802/jmd.18067] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
35 Dardiotis E, Aloizou AM, Sakalakis E, Siokas V, Koureas M, Xiromerisiou G, Petinaki E, Wilks M, Tsatsakis A, Hadjichristodoulou C, Stefanis L, Hadjigeorgiou GM. Organochlorine pesticide levels in Greek patients with Parkinson's disease. Toxicol Rep 2020;7:596-601. [PMID: 32426240 DOI: 10.1016/j.toxrep.2020.03.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 3.5] [Reference Citation Analysis]
36 Munoz-Pinto MF, Empadinhas N, Cardoso SM. The neuromicrobiology of Parkinson's disease: A unifying theory. Ageing Res Rev 2021;70:101396. [PMID: 34171417 DOI: 10.1016/j.arr.2021.101396] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
37 Aloizou AM, Siokas V, Sapouni EM, Sita N, Liampas I, Brotis AG, Rakitskii VN, Burykina TI, Aschner M, Bogdanos DP, Tsatsakis A, Hadjigeorgiou GM, Dardiotis E. Parkinson's disease and pesticides: Are microRNAs the missing link? Sci Total Environ 2020;744:140591. [PMID: 32721662 DOI: 10.1016/j.scitotenv.2020.140591] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
38 Bai F, Li X. Association of Helicobacter pylori treatment with Parkinsonism and related disorders: A systematic review and meta-analysis. Life Sci 2021;281:119767. [PMID: 34216625 DOI: 10.1016/j.lfs.2021.119767] [Reference Citation Analysis]
39 Lolekha P, Sriphanom T, Vilaichone RK. Helicobacter pylori eradication improves motor fluctuations in advanced Parkinson's disease patients: A prospective cohort study (HP-PD trial). PLoS One 2021;16:e0251042. [PMID: 33945559 DOI: 10.1371/journal.pone.0251042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Chandra S, Alam MT, Dey J, Sasidharan BCP, Ray U, Srivastava AK, Gandhi S, Tripathi PP. Healthy Gut, Healthy Brain: The Gut Microbiome in Neurodegenerative Disorders. Curr Top Med Chem 2020;20:1142-53. [PMID: 32282304 DOI: 10.2174/1568026620666200413091101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
41 Alfonsetti M, Castelli V, d'Angelo M. Are We What We Eat? Impact of Diet on the Gut-Brain Axis in Parkinson's Disease. Nutrients 2022;14:380. [PMID: 35057561 DOI: 10.3390/nu14020380] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
42 Mentis AA, Dardiotis E. Helicobacter pylori Eradication for Metachronous Gastric Cancer: An Unsuitable Methodology Impeding Broader Clinical Usage. Front Oncol 2019;9:90. [PMID: 30842937 DOI: 10.3389/fonc.2019.00090] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
43 Ullah I, Zhao L, Hai Y, Fahim M, Alwayli D, Wang X, Li H. "Metal elements and pesticides as risk factors for Parkinson's disease - A review". Toxicol Rep 2021;8:607-16. [PMID: 33816123 DOI: 10.1016/j.toxrep.2021.03.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
44 Madebo MP, Zheng Y, Jin P. Melatonin-mediated postharvest quality and antioxidant properties of fresh fruits: A comprehensive meta-analysis. Compr Rev Food Sci Food Saf 2022. [PMID: 35621156 DOI: 10.1111/1541-4337.12961] [Reference Citation Analysis]
45 Beckers M, Bloem BR, Verbeek MM. Mechanisms of peripheral levodopa resistance in Parkinson's disease. NPJ Parkinsons Dis 2022;8:56. [PMID: 35546556 DOI: 10.1038/s41531-022-00321-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 2020;16:303-18. [PMID: 32332985 DOI: 10.1038/s41582-020-0344-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 28.5] [Reference Citation Analysis]
47 Boziki M, Grigoriadis N, Papaefthymiou A, Doulberis M, Polyzos SA, Gavalas E, Deretzi G, Karafoulidou E, Kesidou E, Taloumtzis C, Theotokis P, Sofou E, Katsinelos P, Vardaka E, Fludaras I, Touloumtzi M, Koukoufiki A, Simeonidou C, Liatsos C, Kountouras J. The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. Neurochem Int 2021;144:104938. [PMID: 33535070 DOI: 10.1016/j.neuint.2020.104938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
48 Dardiotis E, Tsouris Z, Aslanidou P, Aloizou A, Sokratous M, Provatas A, Siokas V, Deretzi G, Hadjigeorgiou GM. Body mass index in patients with Multiple Sclerosis: a meta-analysis. Neurological Research 2019;41:836-46. [DOI: 10.1080/01616412.2019.1622873] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
49 Shen S, Zhang C, Xu YM, Shi CH. The Role of Pathogens and Anti-Infective Agents in Parkinson's Disease, from Etiology to Therapeutic Implications. J Parkinsons Dis 2021. [PMID: 34719435 DOI: 10.3233/JPD-212929] [Reference Citation Analysis]